@FiercePharma: $BMY CEO talks up immuno-oncology space, coming hep C competition in Japan. Article | Follow @FiercePharma
@EricPFierce: ICYMI: Lupin lands its first US manufacturing site with $880M deal for GAVIS, 6-year-old NJ firm. More | Follow @EricPFierce
@CarlyHFierce: About that brand/generics hybrid thing? Make that brands only, Allergan says with Teva deal. News | Follow @CarlyHFierce
> Mylan ($MYL) has picked Aug. 28 for a special shareholder meeting to determine whether to go ahead with its bid for Perrigo ($PRGO). Report
> In H1, Almirall's normalized net profit rose to €63.8 million from €19.1 million in the year-ago period. Report
> Teva's ($TEVA) Monday deal to buy Allergan's ($AGN) generics business for $40.5 billion dwarfed the other four top transactions in Israeli history by at least $30 billion, according to Bloomberg data. More
> GlaxoSmithKline's ($GSK) Nigerian unit reported a 66% drop in first-half profit. Report
Medical Device News
@FierceMedDev: Docs dole out recs for reducing fetal ultrasound procedures in the U.S. Story | Follow @FierceMedDev
@EmilyWFierce: #FDA launches probe into safety of common MRI contrast agent. Article | Follow @EmilyWFierce
> Cepheid readies for 2016 launch of point-of-care molecular Dx system for use anywhere. More
> Micro-cap Nephros secures up to $10M to back its alternative to hemodialysis. Story
Biotech News
@FierceBiotech: Cutting-edge research centers back Deerfield's $550M biotech venture fund. Story | Follow @FierceBiotech
@JohnCFierce: This just in, $SFY has decided to outsource all pipeline work and restrict R&D effort to writing checks. $REGN $ALNY | Follow @JohnCFierce
@DamianFierce: Marc Beer resignation PR includes a line about continuing "the company's commitment to high integrity and ethics." | Follow @DamianFierce
> Progenics' orphan cancer drug picks up the FDA's 'breakthrough' tag. Article
> Cutting-edge research centers back Deerfield's $550M biotech venture fund. More
> Esperion looks to disrupt the PCSK9 race with new cardio data. News
Drug Delivery News
> IPOs: EyeGate tries again following deal with Valeant, Parkinson's specialist to debut soon. More
> Alnylam launches trial of one of its RNAi candidates. Article
> Pill holds a ring-shaped device that could deliver drugs to the stomach long-term. Story
> ASU team offers precise DNA origami technique with novel shapes and delivery potential. More
> Ra Pharma gets $58.5M to challenge a rare disease's intravenous incumbent. Article
Pharma Manufacturing News
> Avista Pharma snaps up NC manufacturing facility from rival Scynexis. Report
> Teva expands recall of cancer drug Adrucil. Story
> Androxy returns to market after 9-month lapse. News
> EU ban on more than 700 drugs set for Aug. 21. Item
> Hospira recall of ketorolac now close to 40 million vials. Article
Pharma Asia News
> Fallout from India's GVK means $1B lost in drug exports by March 2016. News
> Trans-Pacific Partnership impasse on data exclusivity for biologics softens. Story
> Roche COO O'Day highlights emerging markets trends on Q2 call. More
> Eli Lilly execs on Q2 call discuss Japan opportunities, China slowdown. Article
> EU-wide ban starts Aug. 21 on 700-plus drugs tested by India's GVK Bio Sciences. Report
And Finally... Gadolinium-enhancing contrast agents used in MRI imaging may build up in the brain after repeated scans, the FDA warns. More